{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T17:27:51Z","timestamp":1789579671236,"version":"build-2803163510"},"reference-count":50,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,2,23]],"date-time":"2023-02-23T00:00:00Z","timestamp":1677110400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","award":["03Z22JN12"],"award-info":[{"award-number":["03Z22JN12"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Hemolytic-uremic syndrome (HUS) can occur as a complication of an infection with Shiga-toxin (Stx)-producing <jats:italic>Escherichia coli<\/jats:italic>. Patients typically present with acute kidney injury, microangiopathic hemolytic anemia and thrombocytopenia. There is evidence that Stx-induced renal damage propagates a pro-inflammatory response. To date, therapy is limited to organ-supportive strategies. Bruton\u2019s tyrosine kinase (BTK) plays a pivotal role in recruitment and function of immune cells and its inhibition was recently shown to improve renal function in experimental sepsis and lupus nephritis. We hypothesized that attenuating the evoked immune response by BTK-inhibitors (BTKi) ameliorates outcome in HUS. We investigated the effect of daily oral administration of the BTKi ibrutinib (30 mg\/kg) and acalabrutinib (3 mg\/kg) in mice with Stx-induced HUS at day 7. After BTKi administration, we observed attenuated disease progression in mice with HUS. These findings were associated with less BTK and downstream phospholipase-C-gamma-2 activation in the spleen and, subsequently, a reduced renal invasion of BTK-positive cells including neutrophils. Only ibrutinib treatment diminished renal invasion of macrophages, improved acute kidney injury and dysfunction (plasma levels of NGAL and urea) and reduced hemolysis (plasma levels of bilirubin and LDH activity). In conclusion, we report here for the first time that BTK inhibition attenuates the course of disease in murine HUS. We suggest that the observed reduction of renal immune cell invasion contributes \u2013 at least in part \u2013 to this effect. Further translational studies are needed to evaluate BTK as a potential target for HUS therapy to overcome currently limited treatment options.<\/jats:p>","DOI":"10.3389\/fimmu.2023.1105181","type":"journal-article","created":{"date-parts":[[2023,2,23]],"date-time":"2023-02-23T07:22:16Z","timestamp":1677136936000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":8,"title":["Bruton\u2019s tyrosine kinase inhibition attenuates disease progression by reducing renal immune cell invasion in mice with hemolytic-uremic syndrome"],"prefix":"10.3389","volume":"14","author":[{"given":"Sarah","family":"Kr\u00f6ller","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bianka","family":"Wissuwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Dennhardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadine","family":"Krieg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Thiemermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Daniel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerstin","family":"Amann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Gunzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sina M.","family":"Coldewey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,2,23]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.2903\/j.efsa.2021.6971","article-title":"The European union one health 2020 zoonoses report","volume":"19","author":"European Food Safety","year":"2021","journal-title":"EFSA J"},{"key":"B2","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1007\/s40124-020-00208-7","article-title":"Coli hemolytic uremic syndrome: Review of management and long-term outcome","volume":"8","author":"Harkins","year":"2020","journal-title":"Curr Pediatr Rep"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-012-2383-6","article-title":"Long-term outcomes of shiga toxin hemolytic uremic syndrome","volume":"28","author":"Spinale","year":"2013","journal-title":"Pediatr Nephrol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3390\/toxins3060626","article-title":"Shiga toxin interaction with human intestinal epithelium","volume":"3","author":"Schuller","year":"2011","journal-title":"Toxins (Basel)"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1152\/ajprenal.00376.2017","article-title":"Advances in our understanding of the pathogenesis of hemolytic uremic syndromes","volume":"314","author":"Bowen","year":"2018","journal-title":"Am J Physiol Renal Physiol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"119","DOI":"10.12703\/P6-119","article-title":"Management of hemolytic uremic syndrome","volume":"6","author":"Kavanagh","year":"2014","journal-title":"F1000Prime Rep"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1542\/peds.9.6.722","article-title":"Agammaglobulinemia","volume":"9","author":"Bruton","year":"1952","journal-title":"Pediatrics"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1038\/361226a0","article-title":"The gene involved in X-linked agammaglobulinaemia is a member of the src family of protein-tyrosine kinases","volume":"361","author":"Vetrie","year":"1993","journal-title":"Nature"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.01454","article-title":"Bruton\u2019s tyrosine kinase: An emerging key player in innate immunity","volume":"8","author":"Weber","year":"2017","journal-title":"Front Immunol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.clim.2010.06.011","article-title":"TLR signaling and effector functions are intact in XLA neutrophils","volume":"137","author":"Marron","year":"2010","journal-title":"Clin Immunol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.180.12.8048","article-title":"Essential roles for the tec family kinases tec and btk in m-CSF receptor signaling pathways that regulate macrophage survival","volume":"180","author":"Melcher","year":"2008","journal-title":"J Immunol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1111\/bph.15182","article-title":"Inhibition of bruton\u2019s TK regulates macrophage NF-kappaB and NLRP3 inflammasome activation in metabolic inflammation","volume":"177","author":"Purvis","year":"2020","journal-title":"Br J Pharmacol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.668996","article-title":"Bruton\u2019s tyrosine kinase and its isoforms in cancer","volume":"9","author":"Wang","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2018.03.062","article-title":"The development of bruton\u2019s tyrosine kinase (BTK) inhibitors from 2012 to 2017: A mini-review","volume":"151","author":"Liang","year":"2018","journal-title":"Eur J Med Chem"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.02129","article-title":"Bruton\u2019s tyrosine kinase inhibition attenuates the cardiac dysfunction caused by cecal ligation and puncture in mice","volume":"10","author":"O\u2019Riordan","year":"2019","journal-title":"Front Immunol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2018.10.008","article-title":"BTK inhibition ameliorates kidney disease in spontaneous lupus nephritis","volume":"197","author":"Chalmers","year":"2018","journal-title":"Clin Immunol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2020006288","article-title":"The BTK inhibitor ibrutinib may protect against pulmonary injury in COVID-19-infected patients","volume":"135","author":"Treon","year":"2020","journal-title":"Blood"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.01459","article-title":"Modeling hemolytic-uremic syndrome: In-depth characterization of distinct murine models reflecting different features of human disease","volume":"9","author":"Dennhardt","year":"2018","journal-title":"Front Immunol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2021.12.024","article-title":"Divergent roles of haptoglobin and hemopexin deficiency for disease progression of shiga-toxin-induced hemolytic-uremic syndrome in mice","volume":"101","author":"Pirschel","year":"2022","journal-title":"Kidney Int"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1097\/SHK.0000000000001558","article-title":"Involvement of NF-kappaB1 and the non-canonical NF-kappaB signaling pathway in the pathogenesis of acute kidney injury in shiga-toxin-2-induced hemolytic-uremic syndrome in mice","volume":"56","author":"Sobbe","year":"2021","journal-title":"Shock"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ab.2014.08.027","article-title":"Stain-free detection as loading control alternative to ponceau and housekeeping protein immunodetection in Western blotting","volume":"467","author":"Rivero-Gutierrez","year":"2014","journal-title":"Anal Biochem"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2013.10.010","article-title":"The spleen in local and systemic regulation of immunity","volume":"39","author":"Bronte","year":"2013","journal-title":"Immunity"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2010.05.006","article-title":"Neutrophil kinetics in health and disease","volume":"31","author":"Summers","year":"2010","journal-title":"Trends Immunol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1126\/science.1175202","article-title":"Identification of splenic reservoir monocytes and their deployment to inflammatory sites","volume":"325","author":"Swirski","year":"2009","journal-title":"Science"},{"key":"B25","doi-asserted-by":"publisher","first-page":"107123","DOI":"10.1016\/j.intimp.2020.107123","article-title":"Bruton\u2019s tyrosine kinase inhibition attenuates oxidative stress in systemic immune cells and renal compartment during sepsis-induced acute kidney injury in mice","volume":"90","author":"Nadeem","year":"2021","journal-title":"Int Immunopharmacol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2021012039","article-title":"Effect of ibrutinib treatment on hemolytic anemia and acrocyanosis in cold agglutinin disease\/cold agglutinin syndrome","volume":"138","author":"Jalink","year":"2021","journal-title":"Blood"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14030771","article-title":"The role of bruton\u2019s kinase inhibitors in chronic lymphocytic leukemia: Current status and future directions","volume":"14","author":"Robak","year":"2022","journal-title":"Cancers (Basel)"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1004594107","article-title":"The bruton tyrosine kinase inhibitor PCI-32765 blocks b-cell activation and is efficacious in models of autoimmune disease and b-cell malignancy","volume":"107","author":"Honigberg","year":"2010","journal-title":"Proc Natl Acad Sci U S A."},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13051103","article-title":"Bleeding by bruton tyrosine kinase-inhibitors: Dependency on drug type and disease","volume":"13","author":"von Hundelshausen","year":"2021","journal-title":"Cancers (Basel)"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2019.218545","article-title":"Low-dose btk inhibitors selectively block platelet activation by CLEC-2","volume":"106","author":"Nicolson","year":"2021","journal-title":"Haematologica"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-09-808808","article-title":"Oral bruton tyrosine kinase inhibitors selectively block atherosclerotic plaque-triggered thrombus formation in humans","volume":"131","author":"Busygina","year":"2018","journal-title":"Blood"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1055\/s-0039-1687877","article-title":"Btk inhibitors as first oral atherothrombosis-selective antiplatelet drugs","volume":"119","author":"Busygina","year":"2019","journal-title":"Thromb Haemost"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-017-3876-0","article-title":"Pathogenic role of inflammatory response during shiga toxin-associated hemolytic uremic syndrome (HUS)","volume":"33","author":"Exeni","year":"2018","journal-title":"Pediatr Nephrol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V85.7.1696.bloodjournal8571696","article-title":"Fluid shear stress modulates surface expression of adhesion molecules by endothelial cells","volume":"85","author":"Morigi","year":"1995","journal-title":"Blood"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V98.6.1828","article-title":"Verotoxin-1-induced up-regulation of adhesive molecules renders microvascular endothelial cells thrombogenic at high shear stress","volume":"98","author":"Morigi","year":"2001","journal-title":"Blood"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1203\/01.pdr.0000250037.47169.55","article-title":"The functional state of neutrophils correlates with the severity of renal dysfunction in children with hemolytic uremic syndrome","volume":"61","author":"Fernandez","year":"2007","journal-title":"Pediatr Res"},{"key":"B37","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1111\/j.1365-2249.2006.03155.x","article-title":"Relevance of neutrophils in the murine model of haemolytic uraemic syndrome: mechanisms involved in shiga toxin type 2-induced neutrophilia","volume":"146","author":"Fernandez","year":"2006","journal-title":"Clin Exp Immunol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1006\/clin.1996.0188","article-title":"Neutropenia in X-linked agammaglobulinemia","volume":"81","author":"Farrar","year":"1996","journal-title":"Clin Immunol Immunopathol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.44.5.388","article-title":"Neutropenia associated with X-linked agammaglobulinaemia","volume":"44","author":"Kozlowski","year":"1991","journal-title":"J Clin Pathol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2021.03.039","article-title":"Tissue-resident macrophages mediate neutrophil recruitment and kidney injury in shiga toxin-induced hemolytic uremic syndrome","volume":"100","author":"Lill","year":"2021","journal-title":"Kidney Int"},{"key":"B41","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.immuni.2015.11.011","article-title":"The neutrophil btk signalosome regulates integrin activation during sterile inflammation","volume":"44","author":"Volmering","year":"2016","journal-title":"Immunity"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-11-254185","article-title":"Tyrosine kinase btk regulates e-selectin-mediated integrin activation and neutrophil recruitment by controlling phospholipase c (PLC) gamma2 and PI3Kgamma pathways","volume":"115","author":"Mueller","year":"2010","journal-title":"Blood"},{"key":"B43","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/1471-2172-2-4","article-title":"A conditional form of bruton\u2019s tyrosine kinase is sufficient to activate multiple downstream signaling pathways via PLC gamma 2 in b cells","volume":"2","author":"Tomlinson","year":"2001","journal-title":"BMC Immunol"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M107577200","article-title":"Tyrosine residues in phospholipase cgamma 2 essential for the enzyme function in b-cell signaling","volume":"276","author":"Rodriguez","year":"2001","journal-title":"J Biol Chem"},{"key":"B45","doi-asserted-by":"publisher","first-page":"7360","DOI":"10.1038\/ncomms8360","article-title":"Bruton\u2019s tyrosine kinase is essential for NLRP3 inflammasome activation and contributes to ischaemic brain injury","volume":"6","author":"Ito","year":"2015","journal-title":"Nat Commun"},{"key":"B46","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/j.jaci.2017.01.017","article-title":"LRR, and PYD domain-containing protein 3 (NLRP3) inflammasome activity is regulated by and potentially targetable through bruton tyrosine kinase","volume":"140","author":"Liu","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20201656","article-title":"BTK operates a phospho-tyrosine switch to regulate NLRP3 inflammasome activity","volume":"218","author":"Bittner","year":"2021","journal-title":"J Exp Med"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.630479","article-title":"Targeting the NLRP3 inflammasome via BTK","volume":"9","author":"Weber","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"B49","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1186\/s12936-021-03786-z","article-title":"Analysis of spleen histopathology, splenocyte composition and haematological parameters in four strains of mice infected with plasmodium berghei K173","volume":"20","author":"Wang","year":"2021","journal-title":"Malar J"},{"key":"B50","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1080\/01926230600867750","article-title":"Histopathology of the spleen","volume":"34","author":"Suttie","year":"2006","journal-title":"Toxicol Pathol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2023.1105181\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,23]],"date-time":"2023-02-23T07:22:19Z","timestamp":1677136939000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2023.1105181\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,23]]},"references-count":50,"alternative-id":["10.3389\/fimmu.2023.1105181"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2023.1105181","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,23]]},"article-number":"1105181"}}